Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3

Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer

(2012) Zhaoyu Li et al.   CELL

Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma

(2012) Quan-Lin Li et al.   PLoS One

PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia

(2011) M. Kleppe et al.   BLOOD

Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis

(2011) Emilie A. Bard-Chapeau et al.   CANCER CELL

miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males

(2011) R. Jiang et al.   CLINICAL CANCER RESEARCH

Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C

(2011) Yen-Tsung Huang et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case-Control Study

(2011) D. Trichopoulos et al.   JNCI-Journal of the National Cancer Institute

Signal Transducers and Activators of Transcription-3 Binding to the Fibroblast Growth Factor Receptor Is Activated by Receptor Amplification

(2010) A. A. Dudka et al.   CANCER RESEARCH

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

(2010) S Whittaker et al.   ONCOGENE

Gene Expression Profiles in Breast Cancer to Identify Estrogen Receptor Target Genes

(2008) M. Nagai et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Estrogen-Mediated Suppression of the Gene Encoding Protein Tyrosine Phosphatase PTPRO in Human Breast Cancer: Mechanism and Role in Tamoxifen Sensitivity

(2008) Bhuvaneswari Ramaswamy et al.   MOLECULAR ENDOCRINOLOGY